Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Taysha Gene Therapies, Inc. (TSHA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
17 Nov 2023
Manning Paul B
10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
16,566,667
+0%
100,000
$1.63
$163,000.00
SELL
24 Aug 2023
Alam Kamran
Chief Financial Officer, Officer
Taysha Gene Therapies, Inc.
(TSHA)
258,042
-11%
33,000
$2.33
$76,890.00
BUY
16 Aug 2023
Nolan Sean P.
Chief Executive Officer, Director, Officer
Taysha Gene Therapies, Inc.
(TSHA)
1,535,545
+40%
444,444
$0.90
$399,999.60
BUY
16 Aug 2023
Donenberg Phillip B.
Director
Taysha Gene Therapies, Inc.
(TSHA)
114,111
+3703%
111,111
$0.90
$99,999.90
BUY
16 Aug 2023
Stalfort John A III
Director
Taysha Gene Therapies, Inc.
(TSHA)
884,290
+730%
777,778
$0.90
$700,000.20
BUY
16 Aug 2023
Manning Paul B
10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
16,466,667
+100%
16,466,667
$0.90
$14,820,000.00
SELL
12 Jul 2023
Session R.A. II
10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
8,871,747
-0%
85,872
$0.71
$60,770.73
SELL
22 Jun 2023
Session R.A. II
10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
8,957,619
-0%
28,608
$0.70
$20,119.13
SELL
20 Jun 2023
Session R.A. II
10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
8,986,227
-4%
434,615
$0.71
$307,844.00
BUY
16 May 2023
Nagendran Sukumar
President and Head of R&D, Director, Officer
Taysha Gene Therapies, Inc.
(TSHA)
34,226
+17%
5,000
$0.68
$3,400.00
BUY
31 Oct 2022
Manning Paul B
Director, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
1,642,202
+1054%
1,500,000
$2.00
$3,000,000.00
SELL
23 Aug 2022
Alam Kamran
Chief Financial Officer, Officer
Taysha Gene Therapies, Inc.
(TSHA)
266,121
-1%
3,325
$3.47
$11,537.75
SELL
18 Aug 2022
Alam Kamran
Chief Financial Officer, Officer
Taysha Gene Therapies, Inc.
(TSHA)
269,446
-9%
28,675
$3.70
$105,999.12
SELL
5 Jul 2022
PRASAD SUYASH
CMO and Head of R&D, Officer
Taysha Gene Therapies, Inc.
(TSHA)
530,589
-2%
12,861
$3.70
$47,649.79
SELL
29 Jun 2022
PRASAD SUYASH
CMO and Head of R&D, Officer
Taysha Gene Therapies, Inc.
(TSHA)
543,450
-8%
50,139
$3.65
$183,080.88
BUY
2 Feb 2022
Manning Paul B
Director, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
142,202
+339%
201,602
$7.80
$1,571,809.80
BUY
2 Feb 2022
Nagendran Sukumar
Director
Taysha Gene Therapies, Inc.
(TSHA)
29,226
+52%
10,000
$8.01
$80,100.00
BUY
2 Feb 2022
Donenberg Phillip B.
Director
Taysha Gene Therapies, Inc.
(TSHA)
3,000
+100%
3,000
$7.78
$23,340.00
BUY
24 Nov 2021
Manning Paul B
Director, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
34,202
+6%
2,202
$13.19
$29,044.38
BUY
23 Nov 2021
Session R.A. II
President and CEO, Director, Officer, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
9,164,912
+0%
42,518
$12.44
$529,102.40
BUY
23 Nov 2021
Manning Paul B
Director, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
32,000
+166%
20,000
$12.54
$250,800.00
SELL
18 Aug 2021
Alam Kamran
Chief Financial Officer, Officer
Taysha Gene Therapies, Inc.
(TSHA)
300,215
-9%
33,000
$16.88
$557,022.56
SELL
29 Jun 2021
PRASAD SUYASH
CMO and Head of R&D, Officer
Taysha Gene Therapies, Inc.
(TSHA)
593,589
-11%
79,000
$22.63
$1,787,935.60
BUY
20 May 2021
Nolan Sean P.
Director
Taysha Gene Therapies, Inc.
(TSHA)
1,170
+100%
1,170
$22.35
$26,149.50
BUY
14 May 2021
Manning Paul B
Director, 10% Owner
Taysha Gene Therapies, Inc.
(TSHA)
12,000
+100%
12,000
$20.98
$251,760.00
Home